BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

380 related articles for article (PubMed ID: 12587810)

  • 1. Physician-pharmacist comanagement of hypertension: a randomized, comparative trial.
    Borenstein JE; Graber G; Saltiel E; Wallace J; Ryu S; Archi J; Deutsch S; Weingarten SR
    Pharmacotherapy; 2003 Feb; 23(2):209-16. PubMed ID: 12587810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of Pharmacists' Work in a Physician-Pharmacist Collaborative Model for the Management of Hypertension.
    Isetts BJ; Buffington DE; Carter BL; Smith M; Polgreen LA; James PA
    Pharmacotherapy; 2016 Apr; 36(4):374-84. PubMed ID: 26893135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physician-pharmacist collaboration versus usual care for treatment-resistant hypertension.
    Smith SM; Carris NW; Dietrich E; Gums JG; Uribe L; Coffey CS; Gums TH; Carter BL
    J Am Soc Hypertens; 2016 Apr; 10(4):307-17. PubMed ID: 26852290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary care-based, pharmacist-physician collaborative medication-therapy management of hypertension: a randomized, pragmatic trial.
    Hirsch JD; Steers N; Adler DS; Kuo GM; Morello CM; Lang M; Singh RF; Wood Y; Kaplan RM; Mangione CM
    Clin Ther; 2014 Sep; 36(9):1244-54. PubMed ID: 25085406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incremental costs associated with physician and pharmacist collaboration to improve blood pressure control.
    Kulchaitanaroaj P; Brooks JM; Ardery G; Newman D; Carter BL
    Pharmacotherapy; 2012 Aug; 32(8):772-80. PubMed ID: 23307525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-Effectiveness of a Physician-Pharmacist Collaboration Intervention to Improve Blood Pressure Control.
    Polgreen LA; Han J; Carter BL; Ardery GP; Coffey CS; Chrischilles EA; James PA
    Hypertension; 2015 Dec; 66(6):1145-51. PubMed ID: 26527048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Description of pharmacist interventions during physician-pharmacist co-management of hypertension.
    Von Muenster SJ; Carter BL; Weber CA; Ernst ME; Milchak JL; Steffensmeier JJ; Xu Y
    Pharm World Sci; 2008 Jan; 30(1):128-35. PubMed ID: 17710561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deterioration of blood pressure control after discontinuation of a physician-pharmacist collaborative intervention.
    Carter BL; Doucette WR; Franciscus CL; Ardery G; Kluesner KM; Chrischilles EA
    Pharmacotherapy; 2010 Mar; 30(3):228-35. PubMed ID: 20180606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physician-Pharmacist Collaborative Management: Narrowing the Socioeconomic Blood Pressure Gap.
    Anderegg MD; Gums TH; Uribe L; Coffey CS; James PA; Carter BL
    Hypertension; 2016 Nov; 68(5):1314-1320. PubMed ID: 27600181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacist-physician comanagement of hypertension and reduction in 24-hour ambulatory blood pressures.
    Weber CA; Ernst ME; Sezate GS; Zheng S; Carter BL
    Arch Intern Med; 2010 Oct; 170(18):1634-9. PubMed ID: 20937921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparing standard care with a physician and pharmacist team approach for uncontrolled hypertension.
    Bogden PE; Abbott RD; Williamson P; Onopa JK; Koontz LM
    J Gen Intern Med; 1998 Nov; 13(11):740-5. PubMed ID: 9824519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized controlled trial to assess pharmacist- physician collaborative practice in the management of metabolic syndrome in a university medical clinic in Jordan.
    Hammad EA; Yasein N; Tahaineh L; Albsoul-Younes AM
    J Manag Care Pharm; 2011 May; 17(4):295-303. PubMed ID: 21534640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The benefits of physician-pharmacist collaboration.
    Hwang AY; Gums TH; Gums JG
    J Fam Pract; 2017 Dec; 66(12):E1-E8. PubMed ID: 29202145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Team-based care for improving hypertension management among outpatients (TBC-HTA): study protocol for a pragmatic randomized controlled trial.
    Santschi V; Wuerzner G; Chiolero A; Burnand B; Schaller P; Cloutier L; Paradis G; Burnier M
    BMC Cardiovasc Disord; 2017 Jan; 17(1):39. PubMed ID: 28109266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacists' ability to influence outcomes of hypertension therapy.
    Erickson SR; Slaughter R; Halapy H
    Pharmacotherapy; 1997; 17(1):140-7. PubMed ID: 9017775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Failure of computerized treatment suggestions to improve health outcomes of outpatients with uncomplicated hypertension: results of a randomized controlled trial.
    Murray MD; Harris LE; Overhage JM; Zhou XH; Eckert GJ; Smith FE; Buchanan NN; Wolinsky FD; McDonald CJ; Tierney WM
    Pharmacotherapy; 2004 Mar; 24(3):324-37. PubMed ID: 15040645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of a pharmaceutical care intervention on blood pressure control in a chain pharmacy practice.
    Robinson JD; Segal R; Lopez LM; Doty RE
    Ann Pharmacother; 2010 Jan; 44(1):88-96. PubMed ID: 20040704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A multimodal blood pressure control intervention in 3 healthcare systems.
    Magid DJ; Ho PM; Olson KL; Brand DW; Welch LK; Snow KE; Lambert-Kerzner AC; Plomondon ME; Havranek EP
    Am J Manag Care; 2011 Apr; 17(4):e96-103. PubMed ID: 21774100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacoeconomic evaluation of a pharmacist-managed hypertension clinic.
    Okamoto MP; Nakahiro RK
    Pharmacotherapy; 2001 Nov; 21(11):1337-44. PubMed ID: 11714206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physician and pharmacist collaboration to improve blood pressure control.
    Carter BL; Ardery G; Dawson JD; James PA; Bergus GR; Doucette WR; Chrischilles EA; Franciscus CL; Xu Y
    Arch Intern Med; 2009 Nov; 169(21):1996-2002. PubMed ID: 19933962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.